High incidence of thromboembolism in patients with central nervous system lymphoma (Q48198365)

9 February 2018

title

High incidence of thromboembolism in patients with central nervous system lymphoma (English)

1 reference

9 February 2018

1 reference

Neta Goldschmidt

1 reference

9 February 2018

Eduard Linetsky

1 reference

9 February 2018

Edna Shalom

1 reference

9 February 2018

David Varon

1 reference

9 February 2018

Tali Siegal

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

9 February 2018

published in

Cancer

1 reference

9 February 2018

volume

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

1239-1242

1 reference

9 February 2018

Cancer and the prothrombotic state

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Thromboembolism in patients with high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Medical management of patients with brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Thromboembolism in brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Thromboembolism. A complication of weekly chemotherapy in the treatment of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Current status and future of relapsed primary central nervous system lymphoma (PCNSL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Can low-molecular-weight heparins improve outcome in patients with cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and/or hormonal therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11623

7 January 2021

Identifiers

DOI

10.1002/CNCR.11623

1 reference

9 February 2018

release_w5tvnioj4ffnvde4rk75tvqa4m

Fatcat ID

0 references

1 reference

9 February 2018